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ABSTRACT  
Modern drug discovery has led to the development of drug molecules that exhibit high lipophilicity and poor water solubility, which leads to 
problematic bioavailability. Approaches have thus been made to enhance dissolution of poorly water soluble drugs through modifications and 
creation of specific formulations. Metaclopramide is an antiemetic and gastroprokinetic agent, commonly used to treat nausea and vomiting. It 
is absorbed well after oral administration but a significant first pass effect in some human patients may reduce systemic bioavailability to 
30%.The Metaclopramide base is thus modified from Metaclopramide hydrochloride to enhance solubility .This has been achieved by the 
formulating in solid dispersion since Metaclopramide is poorly water soluble. Though it is absorbed well after oral administr ation, a significant 
first pass effect in some patients reduces systemic bioavailability, which can cause adverse side effects. This solid dispersion has then been used 
through transdermal drug delivery. Enhancement of solubility of poorly water soluble drug by solid dispersion may be attributed to particles 
modified characters such as particle size reduction, improved wettability, higher porosity, decreased lattice energy, amorphous state. The main 
objective thus includes modification of drug Metaclopramide  hydrochloride to Metaclopramide base, preparation of solid dispersion of 
modified Metaclopramide  base drug which has poor water solubility, experimental analysis of Metaclopramide base drug and solid dispersion 
products with carriers. 
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INTRODUCTION: 
Metaclopramide is chemically 4-amino-5-chloro-N-[2-
(diethyl amino)ethyl]-2methoxybenzamide..The antiemetic 
action of Metaclopramide is due to its antagonist activity at 
D2 receptors in the chemoreceptor trigger one in the central 
nervous system and this action prevents nausea and 
vomiting triggered by most stimuli. The gastroprokinetic 
activity is mediated by muscarinic activity, D2 receptor 
antagonist activity and 5 HT-4 receptor agonist activities. It 
has a molecular weight of 299.8 and its melting point is 147 
degree Celsius. 
Enhancement of solubility of poorly water soluble drug can 
be done by solid dispersion technique.1,2,3,4 Though there are 
simple techniques to prepare solid dispersions problems are 
often encountered ,such as physicochemical stability of drug 
and vehicle, making suitable formulation of solid dispersion 
of  into dosage forms and scale up of process. 
 
Fig-1:-Structure of Metaclopramide 
R. Vijaya et, al (2012) expressed5 that transdermal drug 
delivery delivers the drug through topical route for systemic 
effect at a predetermined and controlled rate. In this study, 
transdermal films of amitriptyline  HCl  has been formulated 
using polymers of hydroxypropyl cellulose and polyvinyl 
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pyrolidone in different compositions ,the films were then 
evaluated for their physicochemical properties. 
Complexation is one such technique of preparing a solid 
dispersion, wherein the drug is bound to a carrier because of 
weak Vander waals forces and it is released from its bound 
state only when it gets exposed to a suitable chemical 
environment. In this kind of solid mixture a guest molecule 
forms complex with an inert soluble carrier (host molecule) 
in the solid state. One of the most widely used complex 
carriers is within the class of cyclodextrins6,7,8Cyclodextrins 
are a family of cyclic oligosaccharides composed of α- 
(1,4)linked glucopyranose subunits. It is composed of 
interior hydrophobic  cavity, whereas the exterior is highly 
hydrophilic. The lipophilic cavity of cyclodextrin molecules 
provides a microenvironment into which appropriately 
sized non polar moieties can enter to form inclusion 
complex.9 Complex formation between cyclodextrin and a 
substrate is assessed by its binding/stability constant. 
Yvaraja et al,in (2014)10prepared solid dispersion of 
carvedilol for enhancement of aqueous  solubility. To 
increase solubility polymers like Beta Cyclodextrin, 
Hydroxypropyl-beta-cyclodextrin were used. The following 
solid dispersion were then evaluated through phase 
solubility studies, determination of partition coefficient, 
drug content (%) and in vitro dissolution studies. 
Domanska et al in 2011,investigated11 the guest host 
complex formation of three drug derivatives of anthranilic 
acid,mefenamic acid, niflumic acid with 2-hydroxypropyl-β-
cyclodextrin in aqueous solutions. It was found that 
solubility of sparingly soluble drugs has been improved by 
the addition of 2-hydroxypropyl-β-cyclodextrin at two 
temperatures 298.15 K and 310.15 K and two pH values 2 
and 7. 
 
Fig 2:-Structure of Cyclodextrin molecule 
The Biopharmaceutics classification system: 
 It is a system to differentiate drugs on the basis of their 
solubility and permeability. It is a guide for predicting the 
intestinal drug absorption provided by the U.S Food and 
Drug Administration.  
According to the Biopharmaceutics 12,13,14,15 Classification 
System, drug substances are classified as follows: 
1. Class I-high permeability, high solubility: Those 
compounds are well absorbed and their absorption rate is 
usually higher than excretion. 
2. Class II-high permeability, low solubility: The 
bioavailability of those products is limited by their solvation 
rate. 
3. Class III-low permeability, high solubility: The absorption 
is limited by the permeation rate but the drug is solvated 
very fast. If the formulation does not change the 
permeability or gastro-intestinal duration time , then Class I 
criteria can be applied. 
4. Class I-high permeability, high solubility: Those 
compounds have a poor bioavailability. Usually they are not 
well absorbed over the intestinal mucosa and a high 
variability is expected. 
MATERIALS AND METHODS USED: 
Polymers used: 
1. Hydroxypropyl-β-cyclodextrin(HPβCD).(Tokyo Chemical 
Industries Co. Ltd) 
Table 1-Physicochemical properties of HPβCD 
Appearance White crystalline powder 
Solubility in water at 25C 50 g/lit 
Melting point 278 C 
Degree of substitution 4-6 
 
2. Polyvinyl pyrolidone (PVP K-30).(Loba Chemi, Mumbai) 
Solubility Soluble in water, chloroform, alcohol, 
chlorinated hydrocarbons 
Melting point 150-180 C 
Appearance White to light yellow, hygroscopic, 
amorphous powder 
Density 1.2 g/cm3 
Table 2-Physicochemical properties of PVP-K30 
Drug used: 
Metaclopramide HCl(Yarrow Chemical) 
Reagents used: 
Potassium dihydrogen phosphate (Merck Specialities  Pvt 
Ltd.), Sodium hydroxide (Merck Specialities Pvt Ltd.), 
sodium chloride(Qualichems Pvt Ltd New Delhi) 
Solvents used: acetone (Quest Chemicals, Kolkata) , 
methanol (Spectrochem Pvt Ltd. Mumbai), ethanol(obtained 
from departmental store of Pharm Tech. Jadavpur 
University) , Double distilled water(obtained from lab of 
Pharmaceutical Engineering, Pharm Tech dept. Jadavpur 
Univ.) 
Instruments: UV Visible Spectrophotometer (ANALAB, UV 
180), Water bath (Integrated electrolife system by SUNBIM), 
Magnetic stirrer(Trasons,multispins) 
Conversion of Metaclopramide hydrochloride to 
Metaclopramide base form: 
Metaclopramide base form is required which is usually 
available in its hydrochloride form. Required amount of 
Metaclopramide hydrochloride was dispersed in sufficient 
double distilled water followed by stirring until the total 
amount of drug gets fully dissolved. The solution was 
neutralized by 1 M sodium hydroxide solution and gradually 
a precipitate was formed. The precipitate was collected by 
filtration and the precipitate thus obtained was washed 
several times with double distilled water to remove HCl 
which was produced during precipitation. The wet 
precipitate was dried in hot air oven at 50 degrees Celsius. 
Afterwards the solid material was cooled up to room 
temperature (25 degrees Celsius).Next; dried solid material 
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was treated with acetone to make a saturated solution ad 
stirred continuously at 50 degree Celsius. The solution was 
allowed to attain room temperature and thereafter it was 
kept in a refrigerator and crystal particles of 
Metaclopramide (base form) was formed and collected and 
dried in 50 degrees Celsius in hot air oven. The material was 
cooled at room temperature and it was weighed. 
Determination of aqueous solubility of drug: 
Aqueous solubility study was performed by taking excess 
amount of Metaclopramide in an aqueous phase (phosphate 
buffer pH 7.4, double distilled water, phosphate buffer pH 
6.8 and pH 5.5 buffer) and shaken at 37C,40C,45C. After 
24 hours absorbance was observed to obtain solubility. 
Phase solubility study: 
Phase solubility was carried out by dissolving known 
amount of polymers with increasing amount to each of 
series of test tubes containing aqueous phase (phosphate 
buffer pH 7.4, double distilled water).Thereafter excess 
amount of drug was added to each of the tube and shaken for 
24 hour at 25C, 37 C,40 C,45 C respectively. After 24 
hour, very slight quantity of insoluble material(drug) was 
observed at the bottom of each test tube and then content of 
each test tube was filtered and filtrate was collected and its 
absorbance recorded. Phase solubility curve was 
constructed and thermodynamic and binding constants were 
calculated. 
 Preparation of Metaclopramide Solid dispersion:  
Solvent evaporation technique was carried out by dispersing 
physical mixture and polymer at certain common ratio and 
then it was evaporated until transparent solvent free thin 
layer of mass was obtained. Then the film was dried till 
constant weight at 50 degrees Celsius. 
2.6 Characterization of Metaclopramide solid 
dispersion: 
Characterization of solid dispersion was performed by 
instrumental analysis 16,17  like Fourier Transform Infrared 
Spectroscopy (FTIR)   analysis and Differential Scanning 
Calorimetry (DSC) analysis . FTIR analysis was done to 
observe the stability of drug 18,19 and also to confirm drug 
polymer interaction if any. DSC analysis was carried out for 
Metaclopramide loaded solid dispersions, physical mixture 
and also for pure drug to analyze the crystallinity and 
amorphous nature of compounds. 
 RESULTS AND DISCUSSION:  
λmax  of Metaclopramide base determined first by scanning 
solution of Metaclopramide in UV Spectrophotometer. λmax 
was found to be 272 nm. 
Preparation of calibration curve: The standard curves was 
prepared by plotting absorbance against concentration of 
individual analysts. 
 
Table 3: absorbance of Metaclopramide at 272 nm for different concentrations in DDW, pH 5.5 
Serial no: Concentration(µg/mL) Absorbance at 272 nm in 
diff conc. DDW 
Absorbance at 272 nm in 
diff conc.  pH 5.5 
1 2 0.113 0.1018 
2 4 0.2112 0.1972 
3 6 0.3056 0.2844 
4 8 0.411 0.3866 
5 10 0.5112 0.4752 
6 12 0.615 0.5826 
 
The calibration graph was found linear in range of of 2 to 12 g/mL in Double distilled water,pH 5.5 
 
Fig 3: Standard curve in DDW 
 
Fig 4: Standard curve in pH 5.5
The phase solubility study is carried out to determine 
binding/complexation of polymer-drug complexes. These 
complexes effectively modify solubility characteristics of 
drug. Phase solubility studies of binary systems (MET-
HPβCD, MET-PVP K-30)were performed to see effects of 
complexation ability of different carrier systems. The shapes 
of phase solubility profiles were found to be AL type 
isotherms for PVP K-30 and HPβCD. AL type linear profile 
suggests solubility enhancement of a guest molecule as a 
function of carrier’s concentration. The profiles showed 
different values of intercept and slope as temperature and 
pH of media were varied. Stability constant was calculated by 
intercept and slope of linear part of profile. The apparent 
complexation constants(Kc) and thermodynamic parameters( 
∆G,∆H,∆S)of the phase solubility studies with three aqueous 
media(DDW,pH 5.5) at different temperatures(298 K,310 K, 
313 K, 318 K). 
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Table 4: Binding constants and thermodynamic functions for the interactions of Metaclopramide base with various carriers in 
different pH mediums in different temperature 
Carrier  Medium, DDW  Medium,pH 5.5 
 Temp In K Ka(M-1) ∆G,∆H,∆S   
 
 
 
PVP K-30 
298 95.71968 ∆G=-11.3013 
∆H=26.60082 
∆S=0.127188 
  
310 145.0439 ∆G=-12.331 
∆H=237.4796 
∆S=0.83829 
  
313 350.7873 ∆G=-14.519   
 
 
 
 
HPβCD 
298 81.57048 ∆G=-10.905 
∆H=-10.3914 
∆S=0.001723 
61.35846 ∆G=-10.1995 
∆H=-19.0854 
∆S=-0.02982 
310 69.34625 ∆G=-10.5027 
∆H=-7.88385 
∆S=0.008788 
45.53777 ∆G=-9.46071 
∆H=-9.85321 
∆S=-0.00132 
313 67.34263 ∆G=-10.4301 
∆H=-6.46247 
∆S=0.013314 
43.89936 ∆G=-9.36993 
318 64.76378 ∆G=-10.3333 41.68465  
 
Free energy change for these binary combinations was found 
negative which indicate spontaneous solubilization .Free 
energy changes varies from -9 to -11 kJ/mol. It suggests that 
drug may bind with the carrier molecules which are held by 
weak physical forces like Vander waals forces, hydrogen 
bonding and some hydrophobic forces.  
Effect of temperature on k in pH 5.5 was much prominent in 
each binding in comparison with that of DDW. With the rise 
of temperature mobility of ionic species of MET in acidic pH 
increases which in turn possibly inhibits complex formation 
with the carriers. Complexatio is of exothermic type, entropy 
changes were found negative in pH 5.5.Higher K values for 
MET-PVP K-30 system was observed in comparison with that 
of MET-HPCD.MET-PVP K-30 showed low solubility because 
of influence of high stability constant. If stability constant is 
too high it may form a more stable complex so drug may not 
be released out to a greater extent from complexed state.
 
Table 5: Study of solubility at 37 C of binary solid dispersion with carrier HPβCD 
Binary system mcg/mL in DDW mcg/mL in pH 5.5 
HP 0:1 
HP 1:1 
HP 2:1 
HP 3:1 
191.83 
202.04 
353.06 
483.6 
5553.2 
8085.1 
14680.8 
22340.4 
  
Table 6: Study of solubility at 37 C of binary solid dispersion with carrier PVP K-30 
Binary system  mcg/mL in DDW  mcg/ml in pH 5.5 
PVP 0:1 
PVP 1:1 
PVP 2:1 
PVP 3:1 
191.83 
383.67 
489.79 
602.04 
5553.2 
10212.7 
15744..7 
21914.9 
 
 
Fig 5: Effect of carrier (HPβCD) drug ratio of solid dispersion on solubility of MET in DDW 
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Fig 6: Effect of carrier (PVP K-30) drug ratio of solid dispersion on solubility of MET in DDW 
 
In the following tables saturation solubility of solid 
dispersions of Metaclopramide prepared with various 
carriers was shown. Metaclopramide is sparingly soluble in 
double distilled water(DDW).Its aqueous solubility in Double 
distilled water increases linearly keeping drug amount fixed 
when fraction of carrier substance in solid dispersion of drug 
is increased.  As drug amount was fixed (100 mg) its 
solubility was enhanced up to 5:1 and drug amount was not 
much higher on further increase of HPßCD .Enhancement of 
solubility was observed in binary system of carrier drug(3:1) 
in DDW, approximately 2-3 times. 
Solubility in acidic pH of 5.5 was higher than DDW and it was 
observed that solubility of drug in pH 5.5 is 28.95 times 
higher than that of pure drug in DDW samples without any 
carrier substances. 
In case of solid dispersion of PVP K-30, drug solubility 
enhancement was lesser in comparison with that of HPßCD. 
Its solubility increases linearly with the increase of amount 
of carrier in solid dispersion. 
CONCLUSION: 
Poor solubility of new chemical entities is a well known 
problem for the past few decades. Several formulation 
strategies have been proposed to overcome this. Despite the 
imbalance between significant research efforts and the few 
successful marketed formulations the solid dispersion 
technology still holds a key position among the various 
formulation strategies to enhance the aqueous 
solubility/dissolution rate and thereby oral bioavailability of 
poorly soluble compounds. But only few solid dispersion 
products are available in market because many others have 
stability problems. The various processing parameters are 
involved in the preparation of solid dispersion which 
influence  the effectiveness, usefulness, stability, and safety 
of the formulation. The use of systemic experimental design 
along with mathematical optimization is both time and cost 
efficient and its application assures the formulation quality. 
The main objective was to develop modified release dosage 
form of poorly soluble drugs in an attempt to improve oral 
bioavailability20,21. 
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